Search results for: 'specif covid partnering 2025 2025'

Provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals

Respiratory Infection Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts

The Leading Partnering Intelligence Platform for Pharma, Biotech and Diagnostic Dealmakers

Infectious Disease Molecular Diagnostics (MDx) Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts

Specialty Pharmaceutical Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals. 

Syndromic Multiplex Diagnostics Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts

Global Biotech Partnering Terms and Agreements 2018 to 2023 report provides a detailed understanding and analysis of how and why companies enter biotech partnering deals.

Global Generic Pharmaceutical Partnering Terms and Agreements 2010 to 2026 report provides a detailed understanding and analysis of how and why companies enter generic pharmaceutical partnering deals. 

Academic and Non-Profit Partnering Terms and Agreements 2021-2026 provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals. 

The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2026) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.